517. Safety and Tolerability of Intramuscular (IM) Sotrovimab 500 mg Administered at Different Injection Sites: Results from the Phase I COSMIC Study

por Moore, Jennifer, Chen, Wen-Hung, Daniluk, Jerzy, Parra, Sergio, Turner, Megan, Sanchez-Pearson, Yasmin, Sakar, Prosenjit, Hawes, Ian A, Aylott, Alicia
Publicado 2023